Literature DB >> 632977

Galactose-1-phosphate uridyl transferase deficiency due to Duarte/galactosemia combined variation: clinical and biochemical studies.

H L Levy, S J Sepe, D S Walton, V E Shih, G Hammersen, S Houghton, E Beutler.   

Abstract

The most common abnormality detected by the screening of newborn infants for galactosemia is a deficiency of galactose-1-phosphate uridyl transferase due to the presence in one individual of allelic genes for the Duarte variant and for galactosemia. Clinical studies of ten untreated individuals with this genetic compound, including three adults, failed to reveal evidence of cataracts, liver disease, or mental subnormality, the major clinical complications associated with galactosemia. Galactose-1-phosphate was not detectable in umbilical cord blood from one infant. Galactose was not detectable in random blood specimens from any of the individuals and was present in only small amounts following ingestion of milk in one infant and a child. It would appear that this common gentic variation is usually, if not always, benign.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632977     DOI: 10.1016/s0022-3476(78)80425-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Galactose increase in an infant whose mother is heterozygous for peripheral uridine diphosphate galactose-4-epimerase deficiency.

Authors:  K M Keller; S Wirth; A C Sewell; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Komrower Lecture. Galactosaemia today: the enigma and the challenge.

Authors:  S Segal
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

3.  Polymorphism of erythrocyte galactose-1-phosphate uridyltransferase among Chinese.

Authors:  Y K Xu; W G Ng
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

4.  Isoelectrofocusing of erythrocyte galactose 1 phospho uridyl transferase in a family with both galactosemia and Duarte variants.

Authors:  F Schapira; C Gregori; J Banroques; M Vidailhet; S Despoisses; C Vigneron
Journal:  Hum Genet       Date:  1979-01-19       Impact factor: 4.132

5.  Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead.

Authors:  Brook M Pyhtila; Kelly A Shaw; Samantha E Neumann; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2014-04-10

6.  Galactose intolerance and the risk of cataract.

Authors:  A F Winder; P Fells; R B Jones; R D Kissun; I S Menzies; J N Mount
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

7.  Screening of newborn infants for galactosemia in British Columbia.

Authors:  L T Kirby; M G Norman; D A Applegarth; D F Hardwick
Journal:  Can Med Assoc J       Date:  1985-05-01       Impact factor: 8.262

Review 8.  Partial deficiency of galactose-1-phosphate uridyltransferase.

Authors:  R Gitzelmann; N U Bosshard
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

9.  Newborn screening: the genomic challenge.

Authors:  Harvey L Levy
Journal:  Mol Genet Genomic Med       Date:  2014-03       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.